In this Exclusive Interview, Dr. Robert Geho joins Diabetes in Control publisher Steve Freed at the 2016 Diabetes Symposium in Boston to discuss the testing, affects, and potential marketing of a new insulin delivery system currently undergoing trials.
Robert Geho, MD, is a co-founder and CEO of Diasome Pharmaceuticals, Inc. In his role at Diasome, he leads the management and strategic direction of the Company’s targeted insulin therapies, novel type 2 diabetes technology, and oral therapy for obesity.
See the full interview below, or click here if you prefer to view the video broken into shorter segments.
A full transcript of the video is available here.